272 related articles for article (PubMed ID: 29800181)
1. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
[TBL] [Abstract][Full Text] [Related]
2. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
[TBL] [Abstract][Full Text] [Related]
4. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
[TBL] [Abstract][Full Text] [Related]
5. No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial.
Egenvall M; Martling A; Veres K; Horváth-Puhó E; Wille-Jørgensen P; Høirup Petersen S; Laurberg S; Sørensen HT; Syk I;
Eur J Surg Oncol; 2021 Aug; 47(8):2053-2059. PubMed ID: 33846037
[TBL] [Abstract][Full Text] [Related]
6. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
[TBL] [Abstract][Full Text] [Related]
9. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.
Su BB; Shi H; Wan J
World J Gastroenterol; 2012 May; 18(17):2121-6. PubMed ID: 22563201
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.
Fakih M; Sandhu J; Wang C; Kim J; Chen YJ; Lai L; Melstrom K; Kaiser A
JAMA Netw Open; 2022 Mar; 5(3):e221093. PubMed ID: 35258578
[TBL] [Abstract][Full Text] [Related]
11. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
13. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
Søreide K; Søreide JA; Kørner H
World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
16. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
[TBL] [Abstract][Full Text] [Related]
17. [Tumor surveillance after resection of colorectal cancer].
Vorburger SA; Gloor B; Candinas D
Ther Umsch; 2008 Jun; 65(6):329-34. PubMed ID: 18622956
[TBL] [Abstract][Full Text] [Related]
18. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
[TBL] [Abstract][Full Text] [Related]
20. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
